Nantes, France

Mathieu Cinier

This inventor holds 2 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Affilogic, Bracco Imaging Spa. Active years: 2024-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mathieu Cinier

Introduction

Mathieu Cinier is a notable inventor based in Nantes, France. He has made significant contributions to the field of molecular diagnostics, particularly through his innovative patents. With a total of 2 patents, Cinier's work focuses on advancing medical technology and improving diagnostic methods.

Latest Patents

One of Mathieu Cinier's latest patents is titled "ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES." This invention involves the development of proteins that possess multi-specific binding abilities. These proteins are created by fusing an OB-fold variant, particularly from the Sac7d family, to the light or heavy chain of an antibody. This innovative approach has the potential to enhance diagnostic accuracy and efficacy.

Career Highlights

Throughout his career, Mathieu Cinier has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Affilogic and Bracco Imaging Spa. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in molecular diagnostics.

Collaborations

Mathieu Cinier has collaborated with several professionals in his field, including Simon Huet and Olivier Kitten. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Mathieu Cinier is a distinguished inventor whose work in molecular diagnostics has led to significant advancements in the field. His innovative patents and collaborations with industry professionals highlight his commitment to improving medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…